On August 10, 2018 a Exhibit,Appendix was filed involving a dispute between Sinar Seen Individually And As Administrator Of The Estate Of Munir Seen, Deceased, and 84 Lumber Company, Aerco International, Inc., Algoma Hardwoods, Inc., Benjamin Moore & Company, Bmce Inc., In Itself And As Successor To United Centrifugal Pump Co., Cbs Corporation, A Delaware Corporation, F K A Viacom Inc., Successor By Merger To Cbs Corporation, A Pennsylvania Corporation, F K A Westinghouse Electric Corporation, Certain-Teed Corporation, Conwed Corporation, Crane Co., Dap, Inc. N K A La Mirada Products, Inc., Foster Wheeler Energy Corporation, General Electric Company, Industrial Holdings Corporation F K A The Carborundum Company, Ingersoll-Rand Company, Ipa Systems, Inc., John Crane Inc., John Doe 1 Through John Doe 75, Kaiser Gypsum Company, Inc., Kelly Moore Paint Company Inc., Mario & Dibono Fireproofing Corp., Mario & Dibono Plastering Co. Inc., Mckesson Corporation, Metropolitan Life Insurance Company, Pfizer, Inc., Sherwin-Williams Automotive Finishes Corporation, Simpson Timber Company, Tishman Construction Company, Turner Construction Company, Union Carbide Corporation, U.S. Plywood A K A International Paper Company, Weyerhaeuser Company, for Torts - Asbestos in the District Court of New York County.
For full print and download access, please subscribe at https://www.trellis.law/.
Please wait a moment while we load this page.
Preview
FILED: NEW YORK COUNTY CLERK 05/04/2020 11:06 AM INDEX NO. 190225/2018 NYSCEF DOC. NO. 481 RECEIVED NYSCEF: 05/04/2020 Exhibit T FILED: NEW YORK COUNTY CLERK 05/04/2020 11:06 AM INDEX NO. 190225/2018 NYSCEF DOC. NO. 481 RECEIVED NYSCEF: 05/04/2020 St. Joseph's Wayne Medical Center PatientName: SEEN,MUNIRD MRN 627955 Admit 313/2019 FIN 660001840042 Disch: 3/7/2019 DOB/Age/Sex: 4/15/1950 68 years Male Attending: Hafez,MD,Nagwa I Progress Notes Mesothelioma, malignant (C45.0) Postobstructive pneumoria (317) Shortness of breath (E993630C-CD40-4832-B218-2ECF07A2B4F6) No qualifying data avaiable. Medications (101 Active Scheduled: (4) enoxaparin 40 mg/0.4 mL Inj San 0.4 mL 40 mg 0.4 mL,Subcutaneous, Daily levofloxacin 750 mg 150 mL, I Piggyback, Daily morphine 15 mg/ hr Tab 15mg1tab,Oral,BID predniSONE 20 ng Tab 20 mg I tab, Oral, Daily Continuous: (0) PRN:(6) acetaminophen 325 mg Tab 650 mg 2 tab,Oral, Q4H acetaminophen-oxyCODONE 325 mg-Smg Tab 1 tab, Oral, Q6t albuterol-ipratropium 2.5 mg-0,5 mg/3 mL Inh Soln L mL3 rL, Inhale, Q4H docusate-senna 50 mg-8.6 mg Tab 1 tab, Oral, Q12H HYDROmorphone 2 mg/mL Inj Soln 1mL 1 mg 0.5 mL, Slow IV Push, Q4H ondansetron 2 mg/mL Inj Soln 2 mL 4 mg 2 mL, IV Push, Q5H Active Problems (7) At risk for infection Breathing pattern impairment Knowledge deficit Lung cancer Mesothelioma Mesothelioma, malignant Tobacco use Impression: *Acute hypoxemic respiratory failure due to combination ofCOPD exacerbatio/PNA and malignant mesothlioma -SupplementalOxygen Plan for home 02 respiratory failure resolved 2. Postobstructive pncumonia -IV levaquin 3. COPD exacerbation IV steroids Bronchodilators Pulmioniay consult 4. Mesothelioma,malignant D/w the patient. He iswiling to talk to an oncologist about his options of treatment if available(but chemotherapy is not ore of them) 5.Pain control Pain is managed 6.severemalnutrtion CW with offering dietary supplements. Allow pt to eat a non restrictive diet Report Request ID: 7173872 Page 102 of 286 Print Date/Time: 3/19/2019 15:29 EDT